Publication | Closed Access

Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma I. visual acuity after 3 years COMS report no. 16

Ocular DiseaseI-125 BrachytherapyOphthalmologyMelanomaGlaucomaMedicineRadiation OncologyYears Coms Report